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Recent work from our group and others has argued
that human induced pluripotent stem cells (hiPSCs)
generated by the introduction of four viruses bearing
reprogramming factors differ from human embry-
onic stem cells (hESCs) at the level of gene expres-
sion (Chin et al., 2009). Many of the differences seen
were common across independent labs and, at least
to some extent, are thought to be a result of residual
expression of donor cell-specific genes (Chin et al.,
2009; Ghosh et al., 2010; Marchetto et al., 2009).
Two new reports reanalyze similar expression data
sets as those used in Chin et al. (2009) and come
to different conclusions (Newman and Cooper,
2010; Guenther et al., 2010). We compare various
approaches to perform gene expression meta-anal-
ysis that all support our original conclusions and
present new data to demonstrate that polycistronic
delivery of the reprogramming factors and extended
culture brings hiPSCs transcriptionally closer to
hESCs.
INTRODUCTION
The recent advent of reprogramming human somatic cells
to a pluripotent state has led to the examination of human
induced pluripotent stem cells (hiPSCs) and their relation to
human embryonic stem cells (hESCs). Our study (Chin et al.,
2009) demonstrated that hiPSCs generated up until that time
had statistically significant differences in gene expression
compared to available hESCs. Furthermore, many of these
differences, particularly those found in early passage iPSC
lines, were conserved across various studies and species, sug-
gesting that these two cell types, although very similar to each
other, were nonetheless transcriptionally distinguishable. Soon
after, two additional studies came to similar conclusions using
hiPSCs derived from fibroblasts, neural tissue, adipocytes,
and keratinocytes (Ghosh et al., 2010; Marchetto et al., 2009).
These studies went further to propose that residual misexpres-
sion from the cell type of origin is responsible for the observed
differences in gene expression between hiPSCs and hESCs
(Ghosh et al., 2010; Marchetto et al., 2009). Similarly, con-sistent differences in miRNA expression between hiPSCs and
hESCs were also reported (Chin et al., 2009; Wilson et al.,
2009).
hiPSCs and hESCs have also been compared at the level of
the epigenome. In Chin et al. (2009), we showed by chromatin
immunoprecipitation in combination with microarrays (ChIP-
chip) that histone H3K27 and H3K4 trimethylation levels at
promoter regions were not distinguishable between hiPSCs
and hESCs. Hawkins et al., and now Guenther et al., confirmed
that trimethylation of H3K27 was very similar between hESCs
and hiPSCs by ChIP in combination with massive parallel
sequencing (ChIP-Seq) (Hawkins et al., 2010). On the other
hand, it was shown that trimethylation on histone H3K9 is
significantly different between hESCs and hiPSCs and appears
to contribute to the differences in gene expression between
hESCs and hiPSCs seen at early passage (Hawkins et al., 2010).
Along this line, two groups also demonstrated that significant
differences can be detected between hESCs and hiPSCs at the
level of DNA methylation (Deng et al., 2009; Doi et al., 2009),
further indicating that epigeneticmodifications could be differen-
tially affected in the reprogramming process. Furthermore, when
hESCs and hiPSCs from patients with Fragile X (FX) Syndrome
were generated, only the FX-hESCs displayed an active FMR1
locus, whereas reprogramming failed to reactivate this locus
(Urbach et al., 2010). Finally, recent work from our lab suggests
that reprogramming female human fibroblasts under conven-
tional culture conditions fails to reactivate the somatically silent
X chromosome (Tchieu et al., 2010), whereas other work
suggests that hESC lines that capture this primitive state can
be generated (Lengner et al., 2010). In summary, there is consid-
erable evidence that hiPSCs and hESCs are epigenetically and
transcriptionally different at early passage.
Given the vastly different circumstances by which hiPSCs and
hESCs are generated, it is not surprising that these various anal-
yses deem them to have distinct molecular properties. Perhaps
what is most surprising is in fact the high degree to which
transcription factor-induced reprogramming is able to recon-
struct the pluripotent state. A key question then becomes
whether any of the gene expression differences seen between
hiPSCs and hESCs are functionally relevant. Interestingly,
it was shown that different combinations of reprogramming
factors lead to mouse (m) iPSCs with different developmental
potential (Han et al., 2010). Furthermore, recent advances with
mouse reprogramming suggests that miPSC lines can be
derived that possess the same functional characteristics as
mESCs in their capacity to generate mice via tetraploid (4N)Cell Stem Cell 7, 263–269, August 6, 2010 ª2010 Elsevier Inc. 263
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most miPSC lines, even from the same starting population, do
not support 4N complementation. Several new lines of evidence
point to the activity of a few imprinted genes andmiRNAs to be at
least partially responsible for the differences in pluripotency
(Liu et al., 2010; Stadtfeld et al., 2010). Specifically, cell lines
that support 4N complementation express the Dlk1-Dio3
imprinted cluster, whereas those that fail in this approach do
not (Stadtfeld et al., 2010). Thus, misexpression of just a few
genes can functionally distinguish miPSCs from most miPSCs
and mESCs, arguing that even very small differences can have
profound consequences.
Correlating transcriptional differences between hiPSCs and
hESCs with functional differences is considerably more difficult
than in the mouse system because the powerful 4N complemen-
tation assay cannot be applied and quantitative assays to assess
pluripotency are difficult to establish. It is conceivable that all the
hiPSCs generated to date do fall into functional categories that
have yet to be defined, pending the discovery of pluripotency
assays that aremore quantitative than teratoma formation. Given
that we don’t have these defined functional subclassifications of
hiPSCs and hESCs, it is not yet possible to mine human cell
reprogramming expression data for differences that correlate
with functional outputs. It was also suggested that genetic back-
ground contributes significantly to gene expression changes
betweenmESCsandmiPSCs (Stadtfeld et al., 2010), butwhether
this also contributes todifferencesbetweenhESCsandhiPSCs is
still unknown. However, when comparing expression differences
between early passage hiPSCsandhESCsof the reprogramming
experiment from one lab with that from a different lab, we
and others consistently found a significant proportion of genes
to be differentially expressed between these two cell types
(Chin et al., 2009; Ghosh et al., 2010; Marchetto et al., 2009).
We also reported that the overlap of expression differences
decreases as more independent reprogramming experiments
from different labs were compared (Chin et al., 2009).
Regarding the question of consistent differences between
hiPSCs and hESCs, two groups now suggest that when many
lines of hiPSCs and hESCs from different labs are compared,
consistent differences between them are largely lost and that
most expression differences between hiPSCs and hESCs
are lab specific or stochastic in nature (Newman and Cooper,
2010 and Guenther et al., 2010). Both sets of authors performed
their own meta-analysis using similar data sets as presented in
Chin et al. (2009), and the latter went further to derive additional
data from new hiPSCs and compared them with a larger group
of hESCs. Both groups took issue with the meta-analysis
methods used in Chin et al. (2009), and we would like to take
this opportunity to discuss the meta-analyses employed to start
a conversation on ‘‘best practice’’ for meta-analysis of gene
expression of hESCs and hiPSCs. We present a reanalysis of
data from Chin et al. with additional statistical methods to
demonstrate that the conclusions made in Chin et al were in
fact appropriate, and we highlight reasons for the discrepancy
in interpretations between Newman and Cooper, Guenther
et al., and Chin et al. Furthermore, we present data with new
hiPSCs to demonstrate that reprogramming methods may
affect the kinetics of this process and reconfirm that extended
culturing brings hiPSCs closer to hESCs.264 Cell Stem Cell 7, 263–269, August 6, 2010 ª2010 Elsevier Inc.RESULTS AND DISCUSSION
In Chin et al. (2009), we sought to determine differences in gene
expression between hESCs and early passage hiPSCs and to
test the repeatability of the changes seen in among different
independent reprogramming experiments from several labs
(Hochedlinger, Thomson, Jaenisch, and our own). We chose to
analyze the reprogramming experiments from different labs
independently and applied our normalization and differential
gene expression discovery algorithm to each reprogramming
experiment separately. Thus, our normalization strategy was
different from that used in Figure 4 of Guenther et al. (2010)
and Figure 2 of Newman and Cooper (2010) in which both
grouped all samples together and normalized them in a single
event. In preparing Chin et al. (2009), we also found that,
because hESCs and hiPSCs are quite similar to each other,
clustering all data sets from different groups together appeared
to cluster them according to lab of origin, not by cell type.
Because our interest was to compare the differences between
the hiPSCs and hESCs from each group, we believed that inde-
pendent normalization was the appropriate strategy. Since each
reprogramming experiment was treated independently, any
measurement error from a single reprogramming experiment
should have had no influence on data obtained from another.
Given that we found significant overlap between the gene lists
generated as differentially expressed between hESCs and
hiPSCs among different reprogramming experiments, we
argued that these differences were not entirely stochastic (Chin
et al., 2009).
To increase the power of our analysis, we also filtered the
expression data before generating lists of differentially
expressed genes by collapsing the probe expression data for
each gene. To this end, we started by only taking the ‘‘highest
confidence’’ probe sets for a given RefSeq ID and eliminating
probe sets that were defined by Affymetrix as potentially having
more nonspecific binding, then averaged expression data from
remaining probe sets for a given RefSeq to further reduce false
positives. Importantly, by collapsing the probe sets to
characterize each RefSeq ID, wewere able to include expression
data from mouse experiments, which required the use of
Homologene database (NCBI), a function that does not work at
the probe ID level. The extent to which this original approach
contributed to differences in the interpretation of results between
Newman and Cooper (2010), Guenther et al. (2010), and Chin
et al. (2009) is unclear.
To then define significant gene expression differences
between hiPSCs and hESCs, we employed the combination of
a Student’s t test (p = 0.05) and fold change (1.53) in our prior
study (Chin et al., 2009) rather than an approach based on t
testing with false discovery correction (FDR). This approach
was chosen because it was argued that the use of fold change
with a p value cutoff filtering produces lists of differentially ex-
pressed genes in a more reproducible manner (Shi et al.,
2008). However, it has also been proposed that multiple hypoth-
esis testing may be the better method for eliminating noise in
gene expression experiments (Chen and Sarkar, 2006; Grant
et al., 2005; Shedden et al., 2005; Tsai et al., 2003). Therefore,
we have now reanalyzed the same reprogramming data sets
(from Hochedlinger, Thomson, and our own lab) that were
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Figure 1. Overlap of Differentially Ex-
pressed Genes between hiPSCs and hESCs
from Different Labs, Determined with the
Bayesian T Test with FDR Correction and
1.5 Fold Cutoff
Differentially expressed genes between hiPSCs
and hESCs were determined for each of the three
indicated reprogramming experiments (Lowry
et al., 2008; Maherali et al., 2008; Yu et al., 2009)
with a Bayesian t test with a FDR < 0.05 along
with a greater than 1.5 fold change requirement.
In (A), overlap among the differentially expressed
gene lists was only considered if they were differ-
entially expressed in the same direction between
hESCs and hiPSCs. In (B), directionality was not
taken into consideration for the overlap. See also
Figure S1. p values were determined as in Chin
et al., (2009).
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error variance, with an FDR < 0.05 and a 1.5 fold-change cutoff.
This examination found a similar number of genes differentially
expressed between hiPSCs and hESCs in each reprogramming
experiment as described previously in Chin et al. (Figure S1A
available online). Furthermore, the genes differentially expressed
between hESCs and hiPSCs at early passage identified
previously by p value and fold-change cutoff (Chin et al., 2009)
and now by FDR and fold change were 70%–98% identical, indi-Cell Stem Cell 7, 263–26cating that, in this case, the use of p value
and fold change provided a similar strin-
gency to FDR/fold change (Figure S1A).
We also demonstrated in Chin et al.
(Figure S8 in Chin et al., 2009) that even
when taking directionality of expression
differences between early passage
hiPSCs and hESCs into account, there
was still significant overlap between
differential gene expression lists (hiPSCs
versus hESCs) from various labs in over
80% of dual comparisons. Here, we
have also reanalyzed the overlap of differ-
ential gene lists generated by using the
Bayesian t test with FDR correction and
1.5 fold-change cutoff between the
Hochedlinger (Maherali et al., 2008),
Thompson (Yu et al., 2009), and our
reprogramming experiments. We found
that the data sets still have a significant
number of gene expression changes in
common even when directionality of
gene expression differences was taken
into account (Figures 1A and 1B). When
determining the gene expression differ-
ences between hESCs and hiPSCs and
comparing data across different labs or
from independent experiments, it is of
course more likely that those differences
with conserved directionality are more
likely to be functionally relevant.However, until functional data suggest otherwise, it is possible
that even the differences whose direction is not conserved but
still found consistently found in different labs are important.
We have now also performed a post hoc permutation analysis
to estimate the FDR for differentially expressed genes between
hESCs and early passage hiPSCs from different reprogramming
experiments that were determined by p value and fold-change
cutoff in Chin et al. (2009). Although the sample size with only
few hESC and hiPSC lines was not large, this analysis9, August 6, 2010 ª2010 Elsevier Inc. 265
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Figure 2. Variation in Gene Expression
between hiPSCs and hESCs Generated in
Our Laboratories with Different Technical
Strategies
Hierarchical clustering of expression data
obtained for hESCs (blue highlight), various
hiPSCs at different passage (p) (yellow for single
pMX-retroviral hiPSCs, pink for polycistronic
pMIP retroviral hiPSCs, and purple for polycis-
tronic STEMCCA lentiviral hiPSCs), and fibroblasts
(F, black). The Supplemental Experimental Proce-
dures section provides further identification for
each cell line.
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of p value and fold-change cutoff was equal to an approximated
FDR of 2% for early passage hiPSCs versus hESCs (Figure S1B).
Therefore, we conclude that the differentially expressed genes
between early passage hiPSCs and hESCs and the overlap
among different reprogramming experiments as determined
in Chin et al. (2009) are reproducible when using different
analysis tools.
The original hiPSC lines described in Chin et al. (2009) and
Lowry et al. (2008) were generated by the expression of the
Yamanaka set of four transcription factors each from individual
MMLV-based retroviruses (pMX vectors). It has since been
shown that lentivirus is suitable for delivering the reprogramming
factors (Brambrink et al., 2008; Maherali et al., 2008; Stadtfeld
et al., 2008), and newer methods use polycistronic vectors to
deliver all four reprogramming factors in one virus and were
shown to be very effective at generating hiPSC lines (Sommer
et al., 2008; Carey et al., 2009; Chang et al., 2009; Gonzalez
et al., 2009; Shao et al., 2009). To further define gene expression
differences due to reprogramming, we have now generated new
hiPSC lines with various newer methods and under improved
culturing conditions during the reprogramming process. We
took advantage of polycistronic vectors and employed both
a MMLV-based retrovirus and a lentivirus to deliver the reprog-
ramming factors to a variety of fibroblast lines derived from
both males and females (Tchieu et al., 2010) (see Supplemental
Experimental Procedures for a summary of the lines used and
their accession numbers). As shown in Figure 2, all early passage
hiPSC lines generated with polycistronic reprogramming tools
are more similar to hESCs than the hiPSCs made originally in
our lab with four separate viruses each carrying one reprogram-266 Cell Stem Cell 7, 263–269, August 6, 2010 ª2010 Elsevier Inc.ming factor. Together, these data imply
that whereas previous methods to derive
hiPSCs generated lines that could be
distinguished from hESCs by gene
expression as shown in three indepen-
dent studies (Chin et al., 2009; Ghosh
et al., 2010;Marchetto et al., 2009), newer
methods and procedures appear to more
faithfully reprogram fibroblasts to a
pluripotent state.
As shown in Chin et al. (2009), hiPSC
gene expression becomes much more
similar to hESCs as a result of passagingas the gene expression profiles of our late passage pMX-hiPSCs
1, 2, and 18 converged with that of hESCs. Similarly, Soldner
et al. demonstrated that although gene expression differences
were detected between hiPSCs and hESCs, much of this differ-
ence was eliminated upon removal of the reprogramming factors
by Cre-mediated excision (Soldner et al., 2009). Whether
extended passaging due to subcloning played a role in this effect
is unknown. Here, we show that our original pMX-hiPSC lines
when passaged at least 77 times came even closer to hESCs
than they were after 55 passages (Figures 2 and 3). Further-
more, we show that extended passaging of the polycistronic
lines brought them transcriptionally even closer to hESCs
(Figure 3), suggesting that passaging can play a role despite
the method used to reprogram.
It should be noted that the comparisons made in Figure 3 of
Guenther et al. used data from late passage hiPSCs from Chin
et al. but early passage hiPSC lines from Maherali et al. (2008)
and Yu et al. (2009), which could shed light on the differing inter-
pretations of Guenther et al. and Chin et al. (2009). This probably
explains the low number of genes presented in Figure 3C in
Guenther et al. (2010) for theChin et al. data andwhy theMaherali
andYudata sets overlappedwith eachother but notwith theChin
et al. data as they did in the original Chin et al. and in Figure 1A
here.
Our new data are congruent with some new results from
Guenther et al. (2010), showing that newly derived lines made
by polycistronic vectors and passaged significantly in our lab
do not consistently cluster separately from hESCs also grown
in our lab. This finding does not suggest that these newly derived
hiPSCs are identical to hESCs, only that there are fewer differ-
ences between them than found in previous hiPSCs lines
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Figure 3. Extended Passaging Brings the Gene Expression Signature of hiPSCs Closer to that of hESCs
(A) Correlation table comparing normalized and filtered expression data for hESC lines to hiPSCs generated with four separate pMX retroviruses, which were
profiled at different passages (p) as indicated in the yellow highlight. Values present the Pearson’s correlation coefficient between two cell lines.
(B) Correlation table comparing hESC lines to hiPSCs generated with the polycistronic STEMCCA lentivirus at different passages.
(C) Correlation table comparing hESCs to hiPSCs at early passage derived from the three unique reprogramming experiments: 4-factor pMX-hiPSCs (yellow),
polycistronic STEMCCA lentivirus (purple), and polycistronic pMIP retrovirus (pink).
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shows that comparing hiPSCs and hESCs leaves just four genes
with consistent gene expression differences. Although this small
number of differences might be irrelevant, it is worth noting that
just one genetic locus containing several noncoding transcripts
and miRNAs appears to distinguish different functional classes
of miPSCs (Stadtfeld et al., 2010).
In light of these findings, it is important to consider passage
number, reprogramming technology, and genetic background
when comparing pluripotent cells from various sources.
However, it remains unclear what drives the transition of hiPSCs
closer to hESCs. Our data suggest that with improved tech-
nology, one can probe deeper to find expression differences
between hiPSCs and hESCs not related to lab-specific differ-
ences.EXPERIMENTAL PROCEDURES
Tissue Culture and Reprogramming Methods
Cells were cultured and reprogrammed as described in Lowry et al. (2008) and
Tchieu et al. (2010). A summary of the cell lines used in this study is given in the
Supplemental Experimental Procedures. All cells were grown under a protocol
approved by the Embryonic Stem Cell Research Oversight (ESCRO)
committee at UCLA.Gene Expression Analysis
The gene expression profiles of several new hiPSC and hESC as well as fibro-
blast lines was determined by Affymetrix Arrays as described in Chin et al.
(2009) and are summarized in the Supplemental Experimental Procedures
with their NCBI Gene Expression Omnibus (GEO) database accession
numbers. The gene expression data was normalized with Robust Multichip
Analysis (RMA) in R. Probe set data were then collapsed to RefSeqIDs with
the highest confidence probesets as in Chin et al. (2009). A Bayesian t test
was implemented so that differentially expressed genes between hiPSC and
hESC lines could be determined (Baldi and Long, 2001; Sharov et al., 2005).
Genes with an FDR < 0.05 and a fold change greater than 1.5-fold were called
significantly differentially expressed. Significance between any two data sets
was determined with the hypergeometric test, and for three data sets the
significance was measured with a simulation with replacement.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.stem.
2010.06.019.
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